Effects of ouabain on vascular reactivity

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 4, 1997, Pages 545-552

  Vassallo, D V ^a   Songu Mize, E ^b   Rossoni, L V ^a   Amaral, S M C ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

arterial blood pressure; hypertension; Na+ pump; ouabain; phenylephrine; rat tail vascular bed perfusion; vascular reactivity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); OUABAIN; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSOR RESPONSE; RAT;

ANIMALIA; STROPHANTHUS GRATUS;

EID: 0030943335     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-879x1997000400016     Document Type: Conference Paper

References (28)

1. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR & Ludens JH (1991). Identification and characterization of an ouabain-like compound from human plasma. Proceedings of the National Academy of Sciences, USA, 88: 6259-6263.
2. Ludens JH, Clark MA, Robinson FG & DuCharme DW (1992). Rat adrenal cortex is a source of a circulating ouabain-like compound. Hypertension, 19: 721-724.
3. 2+ stores and cell responsiveness. American Journal of Physiology. 264: C1367-C1387.
4. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, Haddy FJ & Pamnani MB (1993). Long-term ouabain administration produces hypertension in rats. Hypertension, 22: 178-187.
5. Goto A, Yamada K, Yagi N, Yoshioka M & Sugimoto T (1992). Physiology and pharmacology of endogenous digitalis-like factors. Pharmacological Reviews, 44: 377-399.
6. Blaustein MP (1988). Sodium/calcium exchange and the control of contractility in cardiac muscle and vascular smooth muscle. Journal of Cardiovascular Pharmacology, 12 (Suppl): S56-S68.
7. Blaustein MP, Goldman WF, Fontana G, Krueger BK, Santiago EM, Steele TD, Weiss DN & Yarowsky PJ (1991). Physiological roles of the sodium-calcium exchanger in nerve and muscle. Annals of the New York Academy of Sciences, 639: 254-274.
8. +-pump in smooth muscle: physiologic and pharmacologic significance. Annual Review of Pharmacology and Toxicology, 20: 129-149.
9. Mulvany MJ (1984). Effect of electrolyte transport on the response of arteriolar smooth muscle. Journal of Cardiovascular Pharmacology, 6: S82-S87.
10. 2+ concentration, and contraction of arterial smooth muscle. Hypertension, 19: 308-313.
11. Skou JC & Esmann M (1992). The Na,K-ATPase. Journal of Bioenergetics and Biomembranes, 24: 249-261.
12. Lingrel JB (1992). Na,K-ATPase: isoform structure, function, and expression. Journal of Bioenergetics and Biomembranes, 24: 263-270.
13. +-ATPase. Biochimica et Biophysica Acta, 988: 185-220.
14. +-ATPase. American Journal of Physiology, 266: H350-H353.
15. +-ATPase alpha-subunit gene expression in hypertension. Science, 241: 221-223.
16. Blaustein MP, Ambesi A, Bloch RJ, Goldman WF, Juhaszova M, Lindenmayer GE & Weiss DN (1992). Regulation of vascular smooth muscle contractility: Roles of the sarcoplasmic reticulum (SR) and the sodium/calcium exchanger. Japanese Journal of Pharmacology, 58 (Suppl 2): 107P-114P.
17. Weiss DN, Podberesky DJ, Heidrich J & Blaustein MP (1994). Nanomolar ouabain augments caffeine-evoked contractions in rat arteries. American Journal of Physiology, 265: C1443-C1448.
18. Vassallo DV, Rashed S, Varner K & Songu-Mize E (1994). Differential effect of ouabain on modulation of vascular reactivity in normotensive and hypertensive rats. FASEB Journal, 8: A300, Abstract 1735.
19. Songu-Mize E, Vassallo DV, Rashed SSK & Varner KJ (1994). Very low concentration of ouabain enhances the phenylephrine-induced contractions in normotensive and hypertensive rat tail arteries. Hypertension, 24: 384, Abstract 68.
20. Songu-Mize E, Vassallo DV, Rashed SM & Varner K (1995). Ouabain amplifies contractile responses to phenylephrine in rat tail arteries in hypertension. Journal of Basic and Clinical Physiology and Pharmacology, 6: 309-318.
21. Amaral SMC, Rossoni LV, Pinto VD & Vassallo DV (1995). Efeito da ouabaína sobre a resposta vasopressora da fenilefrina em ratos normotensos. Anais da X Reunião Anual da FESBE, Abstract 8.50.
22. Rossoni LV, Amaral SMC, Pinto VD & Vassallo DV (1995). Efeito da ouabaína sobre a resposta vasopressora da fenilefrina em ratos hipertensos SHR. Anais da X Reunião Anual da FESBE, Abstract 8.49.
23. Blaustein MP & Hamlyn JM (1991). Pathogenesis of essential hypertension. A link between dietary salt and high blood pressure. Hypertension, 18 (Suppl III): III,184-III,195.
24. Songu-Mize E (1991). Vascular sodium pump activity kinetics in early and advanced stages of deoxycorticosterone-salt hypertension in rats. Life Sciences, 49: 2045-2052.
25. Songu-Mize E, Caldwell RW & Baer PG (1987). High and low dietary potassium effects on rat vascular sodium pump activity. Proceedings of the Society for Experimental Biology and Medicine, 186: 280-287.
26. +-ATPaSe catalyticα isoform and β subunit mRNAs. Journal of Biological Chemistry, 263: 10436-10442.
27. +-ATPase alpha 1, alpha 2, and beta subunit mRNA and protein levels by thyroid hormone. Journal of Biological Chemistry, 265: 14308-14314.
28. Songu-Mize E, Bealer SL & Caldwell RW (1987). Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor. Journal of Hypertension, 5: 461-467.